References
- ConradMFKangJCambriaRPInfrapopliteal balloon angioplasty for the treatment of chronic occlusive diseaseJ Vasc Surg200950479980519786239
- MwipatayiBPHockingsAHofmannMGarbowskiMSieunarineKBalloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysisJ Vasc Surg200847246146917950563
- ChaabaneCOtsukaFVirmaniRBochaton-PiallatMLBiological responses in stented arteriesCardiovasc Res201399235336323667187
- CreelCJLovichMAEdelmanERArterial paclitaxel distribution and depositionCirc Res200086887988410785510
- LevinADVukmirovicNHwangCWEdelmanERSpecific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxelProc Natl Acad Sci USA2004101259463946715197278
- AxelDIKunertWGoggelmannCPaclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug deliveryCirculation19979626366459244237
- KelschBSchellerBBiedermannMDose response to paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation modelInvest Radiol201146425526321285890
- CremersBSpeckUKaufelsNDrug-eluting balloon: very short-term exposure and overlappingThromb Haemost2009101120120619132209
- MargolisJMcDonaldJHeuserRSystemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding studyClin Cardiol200730416517017443649
- GrayWAre all DCB equal?LINCLeipzig, Germany2015 Available from: http://linc2015.cloudcontrolled.com/media/15t_1_1420_Gray.pdfAccessed February 19, 2015
- CremersBBiedermannMMahnkopfDBohmMSchellerBComparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis modelClin Res Cardiol200998532533019280084
- BondessonPLagerqvistBJamesSKOlivecronaGKVenetsanosDHarnekJComparison of two drug-eluting balloons: a report from the SCAAR registryEuroIntervention20128444444922917727
- TepeGDCBs: look to the dataLINC Today – the official newspaper of LINC2015Issue 14
- TepeGZellerTAlbrechtTLocal delivery of paclitaxel to inhibit restenosis during angioplasty of the legN Engl J Med2008358768969918272892
- WerkMLangnerSReinkensmeierBInhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trialCirculation2008118131358136518779447
- WerkMAlbrechtTMeyerDRPaclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trialCirc Cardiovasc Interv20125683184023192918
- ScheinertDDudaSZellerTThe LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplastyJACC Cardiovasc Interv201471101924456716
- CasseseSByrneRAOttIPaclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trialsCirc Cardiovasc Interv20125458258922851526
- RosenfieldKJaffMRWhiteCJLEVANT 2 InvestigatorsTrial of a paclitaxel-coated balloon for femoropopliteal artery diseaseN Engl J Med2015373214515326106946
- TepeGLairdJSchneiderPIN.PACT SFA Trial Investigators. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and/or popliteal peripheral artery disease: 12-month results from the IN.PACT SFA Randomized TrialCirculation2015131549550225472980
- DudaSILLUMENATE FIH: direct DCB cohort – first resultsLINCLeipzig, Germany2015 Available from: http://linc2015.cloudcontrolled.com/media/15th_1_0830_Duda.pdfAccessed February 19, 2015
- SchroederHMeyerDRLuxBRueckerFMartoranaMDudaSTwo-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human studyCatheter Cardiovasc Interv201586227828625708850
- TepeGSchnorrBAlbrechtTAngioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER TrialJACC Cardiovasc Interv201581 Pt A10210825616822
- TepeGZellerTSchnorrBHigh-grade, non-fow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER studyJ Endovasc Ther201320679280024325695
- FanelliFCannavaleABoattaELower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trialJ Endovasc Ther201219557158023046320
- ZellerTBaumgartnerIScheinertDIN.PACT DEEP Trial Investigators. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trialJ Am Coll Cardiol201464151568157625301459
- LiistroFPortoIAngioliPDrug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemiaCirculation2013128661562123797811
- ZellerTBeschornerUPilgerEPaclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II randomized trial (BIOTRONIK’S-first in man study of the Passeo-18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries)JACC Cardiovasc Interv20158121614162226493253
- SchmidtAPiorkowskiMWernerMFirst experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcomeJ Am Coll Cardiol201158111105110921884945
- SteinerSGerman single center experience with Lutonix DCB in BTKLINCLeipzig, Germany2015 Available from: http://linc2015.cloudcontrolled.com/media/15w_1_1454__S.%20Steiner.pdfAccessed February 19, 2015
- StabileEVirgaVSalemmeLDrug-eluting balloon for treatment of superficial femoral artery in-stent restenosisJ Am Coll Cardiol201260181739174223040582
- LiistroFGrottiSPortoIDrug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery)JACC Cardiovasc Interv20136121295130224239203
- TepeGThe Copa Cabana study: DEB vs. POBA in in-stent restenosisLINCLeipzig, Germany2015 Available from: http://linc2015.cloudcontrolled.com/media/15t_1_1620_Tepe.pdfAccessed February 19, 2015
- KrankenbergHTublerTIngwersenMDrug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized femoral artery in-stent restenosis (FAIR) TrialCirculation2015132232230223626446728
- LiistroFAngioliPPortoIPaclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR studyJ Endovasc Ther20142111824502477
- KrankenbergHDCB and ISR: inside from the FAIR studyLINCLeipzig, Germany2015 Available from: http://linc2015.cloudcontrolled.com/media/15t_1_1410_Krankenberg.pdfAccessed February 19, 2015
- GrottiSLiistroFAngioliPPaclitaxel-eluting balloon vs standard angioplasty to reduce restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: three-year results of the DEBATE-ISR studyJ Endovasc Ther2016231525726511896
- TosakaASogaYIidaOClassification and clinical impact of restenosis after femoropopliteal stentingJ Am Coll Cardiol2012591162322192663
- HertenMTorselloGBSchonefeldEImmBOsadaNStahlhoffSDrug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosisJ Vasc Surg201561239439925307133
- SchnorrBKelschBCremersBCleverYPSpeckUSchellerBPaclitaxel-coated balloons – survey of preclinical dataMinerva Cardioangiol201058556758220948503
- YahagiKOtsukaFSakakuraKPathophysiology of superficial femoral artery in-stent restenosisJ Cardiovasc Surg (Torino)2014553307323
- Van den BergJCTowards a better understanding and more efficient treatment of in-stent restenosisJ Cardiovasc Surg (Torino)2014553305306
- FanelliFCannavaleAGazzettiMCalcium burden assessment and impact on drug-eluting balloons in peripheral arterial diseaseCardiovasc Intervent Radiol201437489890724806955
- TepeGBeschornerURuetherCDrug-eluting balloon therapy for femoropopliteal occlusive disease: predictors of outcome with a special emphasis on calciumJ Endovasc Ther201522572773326250747
- Al KhouryGChaerREvolution of atherectomy devicesJ Cardiovasc Surg (Torino)2011524493505
- QuevedoHCArainSAAliGAbi RafehNA critical view of the peripheral atherectomy data in the treatment of infrainguinal arterial diseaseJ Invasive Cardiol2014261222924402808
- AdamsGLKhannaPKStaniloaeCSAbrahamJPSparrowEMOptimal techniques with the Diamondback 360 degrees system achieve effective results for the treatment of peripheral arterial diseaseJ Cardiovasc Transl Res20114222022921312013
- BeschornerUZellerTCombination of mechanical atherectomy and drug-eluting balloons for femoropopliteal in-stent restenosisJ Cardiovasc Surg (Torino)2014553347349
- RastanAMcKinseyJFGarciaLAOne-year outcomes following directional atherectomy of infrapopliteal artery lesions: subgroup results of the prospective, multicenter DEFINITIVE LE TrialJ Endovasc Ther201522683984626445814
- DiamantopoulosAKatsanosKAtherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trialsJ Cardiovasc Surg (Torino)2014555655665
- SixtSCarpio CancinoOGTreszlADrug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteriesJ Vasc Surg201358368268623755977
- GandiniRDel GiudiceCMerollaSMorosettiDPampanaESimonettiGTreatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized studyJ Endovasc Ther201320680581424325697
- TepeGDCB + atherectomy for complex lesions: DEFINITIVE AR – final dataLINCLeipzig, Germany2015 Available from: http://linc2015.cloudcontrolled.com/media/15t_1_1005_Tepe.pdfAccessed February 19, 2015
- DiehmNSchneiderHCost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructionsJ Endovasc Ther201320681982524325699
- PietzschJBGeislerBPGarnerAMZellerTJaffMREconomic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and GermanyCatheter Cardiovasc Interv201484454655424782424
- PietzschJBGeislerBPZellerTEndovascular interventions for treatment of femoropopliteal peripheral artery disease: updated budget impact analysis for Germany based on latest clinical evidenceValue Health2015187A34926531975
- ZellerTRastanAMacharzinaRDrug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesionsJ Endovasc Ther201421335936824915582
- FusaroMCasseseSNdrepepaGPaclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparisonInt J Cardiol201316844002400923890909
- BosiersMPeetersPTessarekJDelooseKStricklerSZilver PTX Single-Arm Study Investigators. The Zilver(R) PTX(R) Single Arm Study: 12-month results from the TASC C/D lesion subgroupJ Cardiovasc Surg (Torino)2013541115122
- DakeMDAnselGMJaffMRSustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studiesJ Am Coll Cardiol201361242417242723583245
- KatsanosKSpiliopoulosSKarunanithyNKrokidisMSabharwalTTaylorPBayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal arteryJ Vasc Surg20145941123113324661896
- SiablisDKitrouPMSpiliopoulosSKatsanosKKarnabatidisDPaclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trialJACC Cardiovasc Interv2014791048105625234679
- SinghGDArmstrongEJLairdJRFemoropopliteal in-stent restenosis: current treatment strategiesJ Cardiovasc Surg (Torino)2014553325333
- WernerMScheinertDHennMEndovascular brachytherapy using liquid Beta-emitting rhenium-188 for the treatment of long-segment femoropopliteal in-stent stenosisJ Endovasc Ther201219446747522891824
- DickPSabetiSMlekuschWConventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experienceRadiology2008248129730218566179
- KarthikSTuiteDJNicholsonAACryoplasty for arterial restenosisEur J Vasc Endovasc Surg2007331404316931070
- WildgruberMGBergerHJCryoplasty for the prevention of arterial restenosisCardiovasc Intervent Radiol20083161050105818535858
- ShinSHBarilDTChaerRAMakarounMSMaroneLKCryoplasty offers no advantage over standard balloon angioplasty for the treatment of in-stent stenosisVascular201321634935423493284
- BosiersMDelooseKCallaertJSuperiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trialJ Endovasc Ther201522111025775672
- ZellerTDakeMDTepeGTreatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stentsJACC Cardiovasc Interv20136327428123517839
- OwensCDwebpage on the InternetLINCLeipzig, Germany2016 Available from: https://linc2016.app.exo.io/media/1040_Christopher_Owens_26_01_2016_Room_1___Main_Arena_1.pdfAccessed March 31, 2016
- HertenMSchönefeldEStahlhoffSSchwindtATorselloGBDrug-coated balloons in the treatment of femoro- and infra-popliteal lesionsInterv Cardiol201574353370